The discovery of nonshivering thermogenesis (NST) and its location in brown adipose tissue (BAT) in the 1950s to 1970s was soon followed by puri®cation of the ®rst uncoupling protein (UCP1) and later by cloning of the gene for UCP1 in 1985. The properties of UCP1 fully explained the long-known phenomenon of stimulated NST in BAT. An additional four`uncoupling proteins' have been cloned in the last two years and are in search of phenomena they can explain. The four speakers in this ®rst session of the symposium on uncoupling proteins reviewed biochemical properties of UCP1 and of three of the novel UCPs. Several suggested functions include mediation of the mitochondrial proton leak in tissues other than BAT, therefore a major role in energy expenditure, and protection against reactive oxygen species. Tools, techniques and information not yet available and for which further research is needed are reviewed.
History
To place the proceedings of this symposium in perspective, a brief history of the subject is presented (see 1,2 for references). The phenomenon of nonshivering thermogenesis (NST) was ®rst understood in the mid1950s as a whole body thermogenic response to noradrenaline that was much increased by acclimation of rats to cold and allowed them to maintain their body temperature without shivering. It was already realized then that it could not be a permanent property of a tissue, but must be subject to being switched on and off in vivo. Although the work of Robert Smith established the thermogenic function of brown adipose tissue (BAT) in the mid-1960s, this tissue was believed to be too small to account for the phenomenon of NST. It was only in the late 1970s that the location of NST in BAT was established by Foster, and the participation of a 32 kDa mitochondrial membrane protein in this process was described by Nicholls. In the meantime, studies of BAT mitochondria and brown adipocytes, particularly by Lindberg's group and by Nicholls, established many of the properties of stimulated thermogenesis in BAT mitochondria (mediated in adipocytes by noradrenaline, inhibited by GDP and stimulated by fatty acids in mitochondria). Puri®cation of the 32 kDa protein by Klingenberg, in vitro translation by Ricquier's group, and sequencing of the protein rapidly followed, but it was 1985 before the gene for the protein now known as uncoupling protein-1 (UCP1) was cloned by Ricquier's group and by Kozak and shown to be uniquely expressed in brown adipocytes. By the late 1970s, demonstration by Rothwell and Stock of the activation of BAT thermogenesis by diet, and by Himms-Hagen of the defective functioning of this tissue in obese animals, established a connection between BAT thermogenesis and energy balance. BAT metabolism became of interest not only to researchers interested in thermoregulation and heat production in a cold environment but also to researchers interested in obesity and its treatment.
Present
In 1997 exactly the opposite sequence of events to that described above was initiated. Three more mammalian putative UCPs have now been cloned and many researchers are in search of their function and of phenomena they can explain. Present guesses, for example mediation of the mitochondrial proton leak, thermogenesis for thermoregulation, regulation of energy expenditure, protection against development of obesity, protection against damage by reactive oxygen species, may be far from reality. Even the use of the name UCPs may be misleading since they may not function as uncoupling proteins, at least not in the same way as UCP1. The recent naming of the third novel UCP as brain mitochondrial carrier protein 1 (BMCP1), rather than UCP4, indicates the rapid recent shift in current opinion of the function of these UCP homologues.
The ®rst session in this Symposium on Uncoupling Proteins and Obesity was devoted to biochemical aspects of UCPs. Martin Klingenberg presented a detailed analysis of structure-function relationships of UCP1. His identi®cation of the amino acid residues at the sites responsible for the translocation of protons, for the binding of GDP, and for the in¯uence of pH on this binding provides an excellent framework for comparing the sequences of UCP2, UCP3 and BMCP1 with the sequence of UCP1 to see whether these various functional sites are conserved in these proteins. For example, targeted mutation of two histidine residues important for proton translocation in UCP1 results in a protein that does not uncouple. That these histidine residues are absent from UCP2 and that only one is present in UCP3 suggests a different function for these proteins. Klingenberg also presented data on use of a glucose-palmitate analogue to show that fatty acid induced uncoupling does not involve a¯ip-¯op mechanism (as postulated by some workers) but rather a direct movement of protons via resident proton-translocating groups in the UCP1.
The proton leak that is demonstrable in isolated mitochondria and in intact cells and believed to be responsible for about 20% of standard metabolic rate (at thermoneutrality, when no energy expenditure for thermoregulatory thermogenesis is occurring) was an obvious candidate for the phenomenon that the novel UCPs, with their far wider tissue distribution than that of UCP1, might underlie. Martin Brand presented a clear exposition of the nature of the proton leak and how it is measured. His conclusion, based on various lines of evidence, was that the mechanism of the leak is uncertain and that current evidence that the novel UCPs might be involved is not convincing. Richard Porter presented data that showed an increased proton leak in liver mitochondria of obaob mice that could be reversed by treatment with leptin. While hepatocytes do not normally express UCP2, this mRNA is expressed in hepatocytes of obaob mice and is correlated with the increased proton leak in the mitochondria. 3 Since obaob mice have reduced energy expenditure, the physiological signi®cance of the increased leak in their hepatocyte mitochondria is uncertain. Increased expression of UCP2 in liver of faafa rats, which have defective leptin receptors, has not consistently been seen, 4 ,5 perhaps a species difference in lack of leptin action.
Much of the evidence that the new UCPs function as uncoupling proteins comes from their in¯uence on growth and on mitochondrial membrane potential when they are expressed in yeast cells. Fre Âde Âric Bouillaud reviewed this evidence, pointing out that expression of UCP1 in yeast produces the expected properties of the mitochondria (inhibition of uncoupling by GDP, stimulation by fatty acids). Expression of UCP2 also produced uncoupling in yeast but there is no effect of GDP or of fatty acids on this. While expression of UCP3L or BMCP1 can likewise induce uncoupling in yeast, expression of UCP3S had no effect. (Other speakers in other sessions also reported on use of yeast expression systems, with Lowell ®nding that both UCP3L and UCP3S were equally good at uncoupling and Reitman ®nding that UCP3 uncoupled.) The principal conclusion drawn from the studies of yeast expression of UCPs is that results are variable and depend on the level of expression of the protein. Moreover, yeast cells have their own endogenous leak, higher than that in rat liver mitochondria. Brand surveyed 32 ± 35 putative members of the yeast carrier family. None has more than 35% identity with UCP1. He concluded that the yeast endogenous leak is not catalyzed by any uncoupling protein.
Bouillaud also reported that transgenic mice expressing UCP1 under the control of the muscle creatine phosphokinase promoter in both heart and muscle have defective skeletal muscle development and function, but have essentially normal hearts, despite the presence of UCP1 in the heart mitochondria. The internal environment of the protein in the cell appears to be as important as the presence of the protein in the mitochondria in determining the function of the protein. Therefore, the ®nding that a protein produces uncoupling in yeast cells does not necessarily mean that it will do so in a different environment in mammalian cells. The original idea about NST, that it should not be a permanent property of a tissue but should be subject to being switched on and off, must be kept in mind in considering functions of the novel UCPs. For example, studies of respiration of brown adipocytes would not yield any information about the presence and functioning of UCP1 if it were not known that noradrenaline should be added to mimic their stimulated function in vivo. The same may be true of other cell types that contain UCP2, UCP3 etc.
Another intriguing piece of information revealed by Bouillaud was that he and his colleagues (Rial and Ricquier) have identi®ed a naturally occurring compound that stimulates respiration of yeast expressing UCP2 but not respiration of yeast expressing UCP3.
Future
Tools, techniques and information not yet available for which further research is needed were enumerated by most speakers. We here highlight some of the most important needs. (1) Effects of targeted gene disruption or of selective tissue overexpression of one or more UCPs to elucidate function. (Hints of transgenic mice to come were mentioned by several participants. Knockout of UCP3 has not so far revealed any speci®c phenotype. Overexpression of UCP2 or UCP3 on the aP2 promoter has likewise not so far revealed any speci®c phenotype.) (2) Speci®c antiBiochemical aspects of the UCPs J Himms-Hagen and M-E Harper bodies for the different isoforms are needed. These need to be suitable for both Western blotting and immunohistochemistry. They must also not crossreact with any other, as yet uncloned, UCPs. Antibodies currently available commercially were agreed to be not suitable. Some antisera prepared against puri®ed UCP1 (from BAT mitochondria) are selective for UCP1 whereas others are not. Moreover, pure protein is needed as a standard for Western blotting and for obtaining quantitative data on the protein levels of UCP isoforms in mitochondria from different tissues. (3) Immunohistochemistry to establish cellular location of UCPs in organs containing many cell types. (4) Quantitative data on the contribution of UCP isoforms to the proton leak, as measured in different cell types, in different species and in isolated mitochondria, and an answer to the question whether the proton leak is a permanent property of a cell or whether it is subject to being switched on and off. (5) Studies of UCPs in puri®ed and reconstituted systems. (6) Identi®cation of inhibitory and stimulatory ligands for the novel UCPs in their natural cellular environment. (7) Cloning of additional homologous proteins. (8) The temperature-dependence of the proton leak appears to be unknown; this may be important in consideration of species that enter seasonal hibernation or daily torpor and needs further study. The up regulation of UCP3 mRNA in muscle of hibernating ground squirrels suggests a role for UCP3 at low temperatures. 6 (9) Further research to answer the question whether development of obesity is associated with altered functioning of one or more of the UCPs.
(10) Development of drugs to selectively stimulate the function of one or more UCPs as a new approach to the treatment of obesity. The cloning of one more member of the UCP family 7 brings the total now known to ®ve.
